Pedro Cascales. Universidad de Murcia. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia, Spain
Jordi Ponce Sebastià. Hospital Universitari de Bellvitge. L´ Hospitalet de Llobregat, Barcelona. Spain

• • 11.00-11.15 – An update on treatment of peritoneal metastasis of endometrial cancer and rare histologies of epithelial ovarian cancer (clear cell, mucinous adenocarcinoma, carcinosarcoma)
    Álvaro Tejerizo. Hospital Universitario 12 de Octubre. Madrid, Spain
    
  • 11.15-11.30 – Less is more or more is more? Surgical decision-making during interval cytoreduction of ovarian cancer treated with neoadjuvant chemotherapy
    Nikolaos Thomakos. “Alexandra” Hospital, National and Kapodistrian University of Athens. Athens, Greece
    
  • 11.30-11.45 – Does PIPAC have a role in the management of recurrent, unresectable peritoneal metastases of ovarian cancer?
    Thanh Dellinger. City of Hope Comprehensive Cancer Center. Duarte, California, USA
  • 11.45-12.00 – When and how to surgically treat recurrent ovarian cancer? From selection criteria to use of HIPEC
    Jean Marc Classe. Institut de Cancérologie de l’Ouest, Nantes, France
  • 12.00-12.30 – Discussion

Sponsored by